Harvard Diabetes and Obesity Implications and Complications 2025

For those of you who provide care to individuals with—or at risk for—diabetes, managing the complex interplay of comorbidities and complications can be challenging. Obesity, a major contributor to the development and progression of diabetes and many of its comorbidities, plays a critical role in patient outcomes and requires targeted strategies for effective management.

With these challenges in mind, Harvard Medical School faculty developed this CME program, Diabetes and Obesity: Complications and Implications, to provide the latest updates, practice recommendations, and evidence-based strategies for optimizing patient care. This program delivers comprehensive education with practical insights to enhance your clinical practice immediately. We will address the following:

• Screening for diabetes and diagnostic criteria for obesity and diabetes
• Clinical approaches to weight management, including lifestyle interventions, pharmacotherapy, and surgery
• Pharmacological management of diabetes, including the latest in insulin and non-insulin therapies and their impact on weight management
• Advances in insulin delivery and glucose monitoring technologies
• Obesity as a comorbidity and its impact on diabetes progression, cardiovascular health, morbidity, and mortality
• Treatment of diabetes-related complications, including dyslipidemia, hypertension, peripheral vascular disease, cardiovascular disease, kidney disease, liver disease, and the diabetic foot
• Care considerations for older adults with diabetes and/or obesity
• Incorporating recent therapeutic advances into your practice
• Challenging patient cases and real-world applications

Education to Optimize Patient Care and Outcomes

Education is focused on optimizing patient care and outcomes and improving skills in the following areas:

• Insulin initiation and intensification: which insulins to choose and why
• Understanding the new insulins, glucose monitors, and pumps
• Treating people with type 2 diabetes who are not achieving therapeutic goals
• Office-based assessment and treatment of comorbidities and complications
• Individualizing multifaceted approaches to lifestyle modification and weight management
• Personalizing nutrition plans and exercise prescriptions
• Cardiovascular risk reduction and care

• Pharmacotherapy for diabetes and obesity: GLP-1 receptor agonists and the spectrum of other options now available
• Optimal management of neuropathies and foot disease
• Managing diabetes in high-risk populations, including pregnant patients and the elderly
• Understanding the evolving concepts and treatments that will soon impact your day-to-day practice
• Communicating with, motivating, and sharing resources with patients
• Recognizing social, racial, sexual, and cultural biases in diabetes care and reviewing strategies for achieving equity and addressing disparities